Rosuvastatin Completed Phase 4 Trials for Metabolic Syndromes Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00395486ROMEO (Rosuvastatin in Metabolic syndrOme)
NCT00815659Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome